Matte Kasi Viswanadh

1.3k total citations · 1 hit paper
33 papers, 812 citations indexed

About

Matte Kasi Viswanadh is a scholar working on Biomaterials, Biomedical Engineering and Molecular Biology. According to data from OpenAlex, Matte Kasi Viswanadh has authored 33 papers receiving a total of 812 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Biomaterials, 15 papers in Biomedical Engineering and 8 papers in Molecular Biology. Recurrent topics in Matte Kasi Viswanadh's work include Nanoparticle-Based Drug Delivery (15 papers), Nanoplatforms for cancer theranostics (10 papers) and Advanced Drug Delivery Systems (6 papers). Matte Kasi Viswanadh is often cited by papers focused on Nanoparticle-Based Drug Delivery (15 papers), Nanoplatforms for cancer theranostics (10 papers) and Advanced Drug Delivery Systems (6 papers). Matte Kasi Viswanadh collaborates with scholars based in India, United States and China. Matte Kasi Viswanadh's co-authors include Madaswamy S. Muthu, Abhishesh Kumar Mehata, Vikas Vikas, Sanjeev Kumar Mahto, Vishnu Priya, Datta Maroti Pawde, Poornima Agrawal, Ankit Kumar Malik, Abhishek Jha and Aseem Setia and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neuroscience and Carbohydrate Polymers.

In The Last Decade

Matte Kasi Viswanadh

31 papers receiving 793 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

WNT-β Catenin Signaling as a Potential Therapeutic Target for Neurodegenerative Diseases: Current Status and Future Perspective

2023 119 citations Kakarla Ramakrishna, Naresh Dumala et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matte Kasi Viswanadh India	15	338	273	242	128	96	33	812
Cuiyan Han China	16	284 0.8×	194 0.7×	273 1.1×	109 0.9×	105 1.1×	42	734
Xiaoying Yang China	12	274 0.8×	174 0.6×	166 0.7×	79 0.6×	70 0.7×	24	790
Khadijeh Ashtari Iran	16	277 0.8×	446 1.6×	381 1.6×	221 1.7×	81 0.8×	32	1.2k
Somayeh Vandghanooni Iran	24	364 1.1×	373 1.4×	541 2.2×	89 0.7×	73 0.8×	45	1.1k
Ziming Zhao China	21	333 1.0×	218 0.8×	374 1.5×	106 0.8×	145 1.5×	56	1.1k
Shouwen Zhang China	15	336 1.0×	408 1.5×	378 1.6×	207 1.6×	31 0.3×	45	1.2k
Yang Deng China	16	219 0.6×	201 0.7×	397 1.6×	59 0.5×	79 0.8×	28	889
Yuanzhi He China	16	208 0.6×	197 0.7×	188 0.8×	145 1.1×	192 2.0×	21	834
Thanh Huyền Trần United States	18	239 0.7×	310 1.1×	413 1.7×	195 1.5×	101 1.1×	32	1.1k
Yi Jia China	17	331 1.0×	303 1.1×	530 2.2×	185 1.4×	85 0.9×	36	1.3k

Countries citing papers authored by Matte Kasi Viswanadh

Since Specialization

Citations

This map shows the geographic impact of Matte Kasi Viswanadh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matte Kasi Viswanadh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matte Kasi Viswanadh more than expected).

Fields of papers citing papers by Matte Kasi Viswanadh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matte Kasi Viswanadh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matte Kasi Viswanadh. The network helps show where Matte Kasi Viswanadh may publish in the future.

Co-authorship network of co-authors of Matte Kasi Viswanadh

This figure shows the co-authorship network connecting the top 25 collaborators of Matte Kasi Viswanadh. A scholar is included among the top collaborators of Matte Kasi Viswanadh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matte Kasi Viswanadh. Matte Kasi Viswanadh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dumala, Naresh, et al.. (2025). Unveiling the Multifaceted Pharmacological Actions of Indole-3-Carbinol and Diindolylmethane: A Comprehensive Review. Plants. 14(5). 827–827. 3 indexed citations

Mehata, Abhishesh Kumar, Vivek Verma, Virendra Singh, et al.. (2025). Fluorescent Calcium Nanocluster-Driven Theranostic Nanoplatforms for Advanced Imaging and Therapy in Breast Tumor. ACS Applied Nano Materials. 8(8). 4026–4039.

Viswanadh, Matte Kasi, Naresh Dumala, Buchi N. Nalluri, et al.. (2025). Morin hydrate: a comprehensive review on therapeutic potential in treating neurological diseases. Nutritional Neuroscience. 29(1). 55–79.

Setia, Aseem, et al.. (2024). Clinical Implications of Proton Pump Inhibitors and Vonoprazan Micro/Nano Drug Delivery Systems for Gastric Acid-Related Disorders and Imaging. Nanotheranostics. 8(4). 535–560. 2 indexed citations

Nakka, Venkata Prasuja, et al.. (2024). Unravelling neuroregenerative and neuroprotective roles of Wnt/β-catenin pathway in ischemic stroke: Insights into molecular mechanisms. Neuroscience. 565. 527–547. 11 indexed citations

Setia, Aseem, et al.. (2024). Targeted Nanotheranostics: Integration of Preclinical MRI and CT in the Molecular Imaging and Therapy of Advanced Diseases. Nanotheranostics. 8(3). 401–426. 8 indexed citations

Pawde, Datta Maroti, et al.. (2024). Integration of Quality by Design (QbD) Principles in the Engineering of an Oral Delivery Nanosystem Loaded with Fenofibrate. International Journal of Pharmaceutical Sciences and Nanotechnology. 17(4). 7492–7503. 1 indexed citations

Vikas, Vikas, Abhishesh Kumar Mehata, Matte Kasi Viswanadh, et al.. (2023). EGFR Targeted Redox Sensitive Chitosan Nanoparticles of Cabazitaxel: Dual-Targeted Cancer Therapy, Lung Distribution, and Targeting Studies by Photoacoustic and Optical Imaging. Biomacromolecules. 24(11). 4989–5003. 16 indexed citations

Mehata, Abhishesh Kumar, Vikas Vikas, Matte Kasi Viswanadh, & Madaswamy S. Muthu. (2023). Theranostics of Metal–Organic Frameworks: Image-Guided Nanomedicine for Clinical Translation. Nanomedicine. 18(8). 695–703. 6 indexed citations

10.

Setia, Aseem, Abhishesh Kumar Mehata, Vikas Vikas, et al.. (2023). Theranostic magnetic nanoparticles: Synthesis, properties, toxicity, and emerging trends for biomedical applications. Journal of Drug Delivery Science and Technology. 81. 104295–104295. 40 indexed citations

11.

Mehata, Abhishesh Kumar, Matte Kasi Viswanadh, Vishnu Priya, Vikas Vikas, & Madaswamy S. Muthu. (2021). Harnessing Immunological Targets for COVID-19 Immunotherapy. Future Virology. 16(9). 619–640. 1 indexed citations

12.

Viswanadh, Matte Kasi, et al.. (2021). Novel redox-sensitive thiolated TPGS based nanoparticles for EGFR targeted lung cancer therapy. International Journal of Pharmaceutics. 602. 120652–120652. 33 indexed citations

13.

Priya, Vishnu, Matte Kasi Viswanadh, Abhishesh Kumar Mehata, et al.. (2021). Targeted Nanotherapeutics in The Prophylaxis and Treatment of Thrombosis. Nanomedicine. 16(13). 1153–1176. 10 indexed citations

14.

Vikas, Vikas, Matte Kasi Viswanadh, Abhishesh Kumar Mehata, et al.. (2021). Bioadhesive chitosan nanoparticles: Dual targeting and pharmacokinetic aspects for advanced lung cancer treatment. Carbohydrate Polymers. 274. 118617–118617. 65 indexed citations

15.

Mehata, Abhishesh Kumar, Matte Kasi Viswanadh, Datta Maroti Pawde, et al.. (2020). Formulation and In Vitro Evaluation of Upconversion Nanoparticle-Loaded Liposomes for Brain Cancer. Therapeutic Delivery. 11(9). 557–571. 20 indexed citations

16.

Viswanadh, Matte Kasi, Vikas Vikas, Abhishek Jha, et al.. (2020). Formulation and In Vivo Efficacy Study of Cetuximab Decorated Targeted Bioadhesive Nanomedicine for Non-Small-Cell Lung Cancer Therapy. Nanomedicine. 15(24). 2345–2367. 26 indexed citations

17.

Gangwar, A., et al.. (2020). Physical and in vitro evaluation of ultra-fine cohenite particles for the prospective magnetic hyperthermia application. Journal of Materials Science Materials in Electronics. 31(13). 10772–10782. 7 indexed citations

18.

Jha, Abhishek, Matte Kasi Viswanadh, Abhishesh Kumar Mehata, et al.. (2020). DNA biodots based targeted theranostic nanomedicine for the imaging and treatment of non-small cell lung cancer. International Journal of Biological Macromolecules. 150. 413–425. 34 indexed citations

19.

Viswanadh, Matte Kasi & Madaswamy S. Muthu. (2018). Targeted Bioadhesive Nanomedicine: An Effective Approach for Synergistic Drug Delivery to Cancers. Nanomedicine. 13(12). 1401–1403. 13 indexed citations

20.

Sonali, Matte Kasi Viswanadh, Rahul Pratap Singh, et al.. (2017). Nanotheranostics: Emerging Strategies for Early Diagnosis and Therapy of Brain Cancer. Nanotheranostics. 2(1). 70–86. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact